News Home

Do Analysts Expect Cardlytics Inc (CDLX) Stock to Rise After It Has Risen 46.05% in a Month?

Friday, December 09, 2022 02:21 PM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Expect Cardlytics Inc (CDLX) Stock to Rise After It Has Risen 46.05% in a Month?

InvestorsObserver is giving Cardlytics Inc (CDLX) an Analyst Rating Rank of 3, meaning CDLX is ranked higher by analysts than 3% of stocks. The average price target for CDLX is $9.8 and analyst’s rate the stock as a Hold.

Overall Score - 2.7
Wall Street analysts are rating CDLX a Hold today. Find out what this means to you and get the rest of the rankings on CDLX!

Why are Analyst Ratings Important?

You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers. InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.

What's Happening With Cardlytics Inc Stock Today?

Cardlytics Inc (CDLX) stock has risen 5.3% while the S&P 500 is lower by -0.11% as of 2:09 PM on Friday, Dec 9. CDLX is higher by $0.27 from the previous closing price of $5.09 on volume of 361,538 shares. Over the past year the S&P 500 is lower by -15.18% while CDLX is lower by -92.39%. CDLX lost -$3.03 per share the over the last 12 months. Click Here to get the full Stock Report for Cardlytics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App